Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea

INTRODUCTION: In 2017, a quadrivalent inactivated split-virion influenza vaccine (QIV; Vaxigrip Tetra(®), Sanofi) was licensed in South Korea for active immunization against influenza A and influenza B viruses in individuals aged 3 years or older, which was subsequently extended to individuals aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sookyung, Li, Xiaoling, Syrkina, Olga, Fournier, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450834/
https://www.ncbi.nlm.nih.gov/pubmed/36070176
http://dx.doi.org/10.1007/s40121-022-00685-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450834/
https://www.ncbi.nlm.nih.gov/pubmed/36070176
http://dx.doi.org/10.1007/s40121-022-00685-x

Ejemplares similares